MedTrace Logo

Evolution of Coronavirus Disease 2019 (COVID-19) Patients in Extremadura

NCT04724850 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 440

Last updated 2024-05-08

No results posted yet for this study

Summary

At the end of January 2020, the international community was informed of the presence of a new viral disease that started in Wuhan (China) and spread rapidly throughout the world. The identified virus belonged to the coronavirus family (SARS-CoV-2) and the disease was named COVID-19. Today there are more than 2 million people diagnosed in Spain and more than 40 thousand in Extremadura. The partial knowledge about the development, evolution of the affected citizenship and their prognosis both early and late makes it necessary to analyze in depth their global and particular characteristics.

We will carry out a multicenter, observational, descriptive, cross-sectional and longitudinal study of patients diagnosed with SARS-CoV-2 virus infection in the Community of Extremadura to determine the effectiveness of drug treatments and the clinical and evolutionary characteristics of these patients and the different factors that may influence its evolution.

Conditions

  • Coronavirus Disease 2019

Sponsors & Collaborators

  • Juan Fernando Masa Jiménez

    lead OTHER

Principal Investigators

  • Juan F Masa Jiménez, PhD · Servicio Extremeño de Salud

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-14
Primary Completion
2022-12-20
Completion
2022-12-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04724850 on ClinicalTrials.gov